Ryan Preblick
Director of Finance/CFO chez INDIVIOR PLC
Fortune : 1 M $ au 31/03/2024
Profil
Ryan Preblick is currently the Chief Financial Officer & Executive Director at Indivior PLC since 2020.
He is also currently the Chief Financial Officer, Secretary & Treasurer at Opiant Pharmaceuticals, Inc. Mr. Preblick completed his undergraduate degree at The Pennsylvania State University and holds an MBA from the University of Richmond.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INDIVIOR PLC
0,05% | 15/03/2024 | 68 386 ( 0,05% ) | 1 M $ | 31/03/2024 |
Postes actifs de Ryan Preblick
| Sociétés | Poste | Début |
|---|---|---|
| INDIVIOR PLC | Director of Finance/CFO | 29/06/2020 |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formation de Ryan Preblick
| The Pennsylvania State University | Undergraduate Degree |
| University of Richmond | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
